Ubitus Unveils Next-Gen AI Innovations at NVIDIA AI Summit Japan 2024
Ubitus K.K.(hereafter Ubitus), a global leader in cloud streaming, is showcasing a range of AI innovations at the NVIDIA AI Summit Japan 2024 in Tokyo on November 13th. During the summit, Ubitus will unveil three AI-driven innovations powered by NVIDIA technologies, poised to transform sectors from gaming to broader industries.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241111755731/en/
Ubitus invites attendees to visit Gold sponsor section booth19 at the NVIDIA AI Summit Japan 2024 in Tokyo on November 13th. (Graphic: Business Wire)
LLM-Driven Robotic AI: Pioneering Human-Robot Interaction
Ubitus is unveiling its LLM-driven AI robot technology, powered by NVIDIA Jetson as the robot's core and seamlessly integrated with a large language model running on the high-performance H100 GPU. Users can issue commands to the robot in natural language, enabling it to understand and respond without complex programming. Ubitus has also incorporated visual recognition capabilities, allowing the robot to identify specific objects through its camera upon receiving commands. This breakthrough has versatile applications across sectors such as security, healthcare, and retail—setting a new standard for intuitive, real-time robotic applications.
NVIDIA ACE-Powered Digital Humans in UE5: Redefining Lifelike Virtual Interaction
Ubitus is also showcasing the digital human created with Unreal Engine 5 (UE5) and powered by NVIDIA ACE, marking a significant advance in interactive digital experiences. These virtual beings feature conversation memory, background knowledge retrieval (RAG), and multilingual capabilities, enabling dynamic, context-aware interactions. Their facial expressions and emotional responsiveness offer a lifelike and immersive experience. By combining these intelligent interaction features with cloud streaming, Ubitus delivers seamless, immersive experiences accessible on various devices—revolutionizing user engagement.
AI VTuber Ubi-chan with Apple Vision Pro: New Devices Enhance Immersive Interaction Experience
Ubi-chan, powered by NVIDIA Riva's text-to-speech and Audio-to-Face lip-syncing technology, responds instantly to voice prompts, converting speech into fluid lip movements for a lifelike performance. Using NVIDIA's automatic speech recognition (ASR) and advanced hand-tracking technology, users can interact with Ubi-chan and witness her realistic reactions to touch-like gestures. This breakthrough breathes new life into AI virtual characters, establishing an unprecedented standard for virtual interactive experiences.
Wesley Kuo, CEO of Ubitus, expressed his excitement about the event: "As a leader in AI and cloud gaming, Ubitus is committed to showcasing the future of AI-driven interactions. The NVIDIA AI Summit Japan provides the perfect platform to highlight how our solutions can drive innovation in multiple industries."
Ubitus invites attendees to visit Gold sponsor section booth19 for live demonstrations of these revolutionary AI technologies and to explore how they are shaping the future of human-computer interaction.
About Ubitus
Ubitus K.K. is a technology leader specializing in GPU virtualization, cloud solutions, and streaming platform. Our focus is on delivering exceptional cloud and AI services and values to customers. Leveraging the power of GPUs, Ubitus has developed a broad range of AI solutions, including UbiGPT (Taiwan LLM), Ubi Anchor (AI anchor), Ubi-chan (AI avatar), and UbiArt (image and video generation software). Ubitus is committed to delivering tailor-made solutions designed to meet the diverse requirements of customers in various industries. Ubitus’ cloud gaming solution enables users to enjoy AAA gaming experiences across devices. Through our comprehensive Game Development Kit (GDK) and game library, we offer a one-stop solution and rapid deployment, catering towards international clients that are interested in cloud gaming. For metaverse applications, Ubitus possesses extensive global cloud deployment resources to stream interactive media content for platform operators and digital content developers.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241111755731/en/
Contacts
Media Contact
TEL: +81-3-6435-3295 (Tokyo)
+886-2-2717-6123 (Taipei)
Media contact: pr@ubitus.net
Business inquiry: contact@ubitus.net
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom